Search the Newsreel

Icon PLC (ICLR) Shares Fall 7.1% -- What GF Score of 88 Tells In

Icon PLC (ICLR) shares recently fell 7.1% to $165.53, yet the company holds a strong GF Score of 88/100, indicating solid fundamentals and growth potential. Despite a high historical P/E, ICLR is considered "modestly undervalued" by GuruFocus, with a GF Value of $227.59, suggesting …

Icon Q1 2026 Earnings Call Transcript

ICON reported strong Q1 2026 financial results, with gross bookings up 22% year-over-year and net business wins of $2.88 billion. The company reaffirmed its full-year 2026 guidance for revenue and adjusted diluted EPS, expecting modest sequential margin improvement. Strategic investments in central labs, oncology …

ICON Public Limited Company 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ICLR) 2026-07-30

ICON reported strong Q1 2026 financial results, with gross bookings up 22% year-over-year and net business wins of $2.88 billion. The company reaffirmed its full-year 2026 guidance for revenue and adjusted diluted EPS, expecting modest sequential margin improvement. Strategic investments in central labs, oncology …

Earnings call transcript: ICON beats Q2 2026 estimates but shares slip premarket

ICON reported strong Q1 2026 financial results, with gross bookings up 22% year-over-year and net business wins of $2.88 billion. The company reaffirmed its full-year 2026 guidance for revenue and adjusted diluted EPS, expecting modest sequential margin improvement. Strategic investments in central labs, oncology …

ICON PLC earnings beat by $0.01, revenue topped estimates

ICON PLC reported second-quarter earnings per share (EPS) of $2.56, surpassing analyst estimates by $0.01. The company's revenue for the quarter reached $2.06 billion, exceeding the consensus estimate of $2 billion. ICON PLC's stock price has increased by 57.50% in the last three months, …

ICON Reports Second Quarter 2026 Results

ICON plc reported its financial results for the second quarter ended June 30, 2026, with revenue reaching $2,063.5 million and adjusted diluted earnings per share of $2.56. The company reaffirmed its full-year 2026 financial guidance, anticipating revenue between $7,850 and $8,150 million, and adjusted …

Fund Update: 1,098,204 ICON PLC (ICLR) Shares Added to GREENHAVEN ASSOCIATES INC Portfolio

GREENHAVEN ASSOCIATES INC has significantly increased its stake in ICON PLC (ICLR) by adding 1,098,204 shares to its portfolio, bringing its total holdings to 1,697,639 shares. This makes GREENHAVEN ASSOCIATES INC the 19th largest institutional investor in ICLR, with its investment now valued at …

ICON plc Q2 Results: Revenue rises 1.2% YoY, adjusted EPS falls

ICON plc reported a 1.2% year-on-year revenue increase in Q2 2026, reaching $2,063.5 million, but saw its adjusted EPS decline to $2.56 due to restructuring and integration costs. Despite this, the company reaffirmed its full-year 2026 adjusted EPS guidance of $10.00-$11.00 and revenue guidance …

ICON plc (NASDAQ: ICLR) Q2 2026 results show bookings strength and lower EPS

ICON plc reported Q2 2026 revenue of $2,063.5 million, marking a 1.2% year-on-year increase, but saw GAAP diluted EPS fall significantly to $0.94 from $2.56 a year earlier, and adjusted diluted EPS to $2.56 from $3.52. Despite the earnings compression and a $32.9 million …

Icon PLC (ICLR) Lags Q2 Earnings Estimates

ICON Shares Rise on Anthropic Collaboration to Bring AI Across Clinical Trials

ICON plc (ICLR) saw its shares rise following an announcement of a collaboration with Anthropic, an AI safety and research company. This partnership aims to integrate Anthropic's generative AI, Claude, into ICON's clinical trial operations, enhancing efficiency, improving data analysis, and accelerating patient outcomes. …

ICON stock surges 7% on Anthropic AI partnership for trials By Investing.com

ICON plc shares rose 7.8% following the announcement of a multi-year collaboration with Anthropic. The partnership aims to integrate Claude AI capabilities across the clinical trial lifecycle to enhance ICON’s Orbis platform and address operational challenges in clinical development, particularly study enrollment. This collaboration …

ICON plc Announces Multi-Year Collaboration With Anthropic To Bring Frontier AI To Clinical Trials

ICON plc has announced a multi-year collaboration with Anthropic to integrate Claude's AI capabilities into clinical trials. This partnership aims to enhance ICON's digital innovation and AI strategy by developing four key production capabilities within its Orbis platform, including site intelligence, predictive intelligence, protocol …

ICON plc rises after Anthropic deal, IQVIA earnings (ICLR:NASDAQ)

ICON plc (ICLR) saw its stock rise following an announcement of a multi-year partnership with Anthropic. The entire contract research organization (CRO) sector benefited from peer IQVIA Holdings' (IQV) better-than-expected Q2 earnings report, contributing to ICON plc's positive performance.

ICON PLC (ICLR) Cash Flow

The article provides a detailed cash flow statement for ICON PLC (ICLR), presenting historical quarterly and annual financial data related to operating, investing, and financing activities. It also includes an FAQ section explaining different types of cash flow and their significance for investors, along …

ICLR|ICON PLC|Price:170.260|Chg%:+2.980

ICON Public Limited Company (ICLR) provides outsourced services to pharmaceutical, biotechnology, medical device, and government organizations, helping bring new drugs and devices to market. The company offers a wide range of services including clinical research, consulting, laboratory services, and real-world intelligence. As of the …

ICLR: Icon Plc Latest Stock Price, Analysis, News and Trading Ideas

This article provides details on Icon Plc (ICLR) stock, including its latest price, market capitalization, volume, and P/E ratio. It also highlights recent news such as its performance since the last earnings report and upcoming earnings call, alongside trending discussions and comparisons with other …

Earnings Preview: Icon PLC to Report Financial Results Post-market on July 29

Icon PLC is scheduled to release its financial results post-market on July 29. Investors will be looking for insights into the company's performance, growth drivers, and future outlook as it prepares to report its earnings. The report will provide key financial metrics that could …

Icon PLC (ICLR) Up 5.8% Since Last Earnings Report: Can It Continue?

Icon PLC (ICLR) shares have risen 5.8% since its last earnings report, outperforming the S&P 500. The company's Q1 2026 earnings beat estimates, with revenues up 0.9% year-over-year. Despite recent positive trends and upward-trending estimates, Zacks Investment Research currently rates ICLR a "Strong Sell."

ICON plc to announce Q2FY26 results on July 29

ICON plc will release its Q2FY26 financial results after market close on July 29, 2026. A conference call and webcast to discuss these results will be held on July 30, 2026, at 8:00 AM ET, with a replay available shortly thereafter. This announcement provides …

Press Release: ICON Schedules Second Quarter 2026 Earnings Conference Call

ICON plc (NASDAQ: ICLR) is scheduled to release its second quarter 2026 earnings on Thursday, July 30, 2026, before the stock market open. The company will also host a conference call and webcast at 8:00 AM EDT to discuss the results. Interested parties can …

ICON plc (NASDAQ: ICLR) schedules Q2 2026 earnings results call

ICON plc announced it will release its second-quarter 2026 financial results after market close on Wednesday, July 29, 2026. A conference call and webcast to discuss these results and business performance is scheduled for Thursday, July 30, 2026, at 8:00 AM ET. ICON, a …

Hybrid Clinical Research Job at ICON plc | Apply Online Now!

ICON plc is offering a hybrid Clinical Data Coordinator II position in Bangalore, Chennai, and Trivandrum for individuals with a life sciences background and clinical data management experience. This role involves maintaining eCRFs, reconciling data, ensuring data quality, and collaborating with cross-functional teams in …

ICON PLC : Leerink Partners Raises Target Pri

This article indicates that Leerink Partners has raised its target price for ICON PLC.

ICON PLC (ICLR) earnings arrive after a 43.0% twelve-week rebound

The clinical-research outsourcer has recovered sharply, but trend and relative-strength readings leave the setup mixed into results.

ICON PLC (ICLR) approaches earnings with rebound intact but confirmation uneven

The clinical-research stock has recovered sharply over 12 weeks, while negative Relative Strength and an inactive trend state keep the setup from looking clean.